AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-2955395_ITM" title="Facts and information about Meds and breast-feeding.(Letters)(Letter to the Editor)">Meds and breast-feeding.(Letters)(Letter to the Editor)</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Meds and breast-feeding.(Letters)(Letter to the Editor)
I must remark on the comments by Dr. Dawn A. Marcus in the article "Manipulate Estrogen Levels to Treat Hormonal Headache" (March 15, 2004, p. 10).
I appreciate her advocacy for nursing migraineurs but must point out that the American Academy of Pediatrics approves sumatriptan succinate for use in breast-feeding mothers.
As both an ob.gyn. and an internationally board certified lactation consultant, I often see patients who have been told to "pump and dump" while using medications that are either approved for use in breast-feeding or ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Experts Say Bioidentical Hormone Therapy Can Treat Hormonal Imbalances...
- Press release article from: Business Wire November 28, 2005 700+ words
CHICAGO -- For most 30-something women, worrying about hormonal changes is a problem they don't think they'll have to face until they've developed more than just a few grey hairs or at least had a grandchild. But doctors say even women in their 30's can experience unpleasant menopausal symptoms
- Standard therapies work, too: manipulate estrogen levels to treat hormonal...
- Magazine article from: OB GYN News Finn, Robert March 15, 2004 700+ words
CANCUN, MEXICO -- Estrogen seems to exacerbate headache in women by at least two mechanisms, but the resulting hormonal headaches can be treated by standard short-term and preventive therapies in addition to manipulating levels of estradiol, according to Dr. Dawn A. Marcus. Cycling estradiol
- Thomas Hale Boggs, Jr. Joins 1-800 CONTACTS Board of Directors.
- Press release article from: PR Newswire December 11, 2002 700+ words
1-800 CONTACTS, INC., , today announced that Thomas Hale Boggs, Jr., Chairman of the Executive Committee and Partner of Patton Boggs has joined 1-800 CONTACTS' Board of Directors...
- Thomas Hale Boggs Jr. Joins Advisory Board of Diligence LLC; Patton Boggs...
- Press release article from: PR Newswire July 8, 2002 700+ words
WASHINGTON -- Diligence LLC, information, due diligence and risk assessment specialists advising premier multinational clients, announced today that Thomas H. Boggs Jr., the prominent Washington lawyer and lobbyist, has joined the firm's blue ribbon advisory board. Boggs, who serves as chairman of
- Zonagen Announces 2006 Annual Meeting of Stockholders; Shareholder Approval...
- Press release article from: Business Wire February 8, 2006 700+ words
...focus. With our new focus on the development of drugs to treat hormonal and reproductive system disorders, we feel that the name...biopharmaceutical company engaged in the development of new drugs to treat hormonal and reproductive system disorders. E[acute accent]Any...
- Zonagen Announces Positive Top-Line Results of Androxal(TM) Study; Androxal(TM)...
- Press release article from: Business Wire February 3, 2006 700+ words
...biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders, today announced positive...biopharmaceutical company engaged in the development of new drugs to treat hormonal and reproductive system disorders. Any statements that...
- Zonagen Receives IRB Approval to Commence Phase III Study of Androxal(TM) for...
- Press release article from: Business Wire January 9, 2006 700+ words
...biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders, today announced that...biopharmaceutical company engaged in the development of new drugs to treat hormonal and reproductive system disorders. Any statements that...
- Forum Alert: Zonagen, Inc. will Present at Informed Investors...
- Press release article from: Business Wire June 8, 2005 700+ words
...clinical-stage biopharmaceutical company focused on the development of new, orally administered, small molecule drugs to treat hormonal and reproductive system disorders. The Company's two main products are Progenta(TM) for the treatment of adverse symptoms...
Source: HighBeam Research, Meds and breast-feeding.(Letters)(Letter to the Editor)